Jonathan T Jan, MD | |
400 S Loop 336 W, Conroe, TX 77304-3302 | |
(936) 539-4500 | |
(936) 539-4050 |
Full Name | Jonathan T Jan |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 12 Years |
Location | 400 S Loop 336 W, Conroe, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1952661118 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | ME132573 (Florida) | Secondary |
207W00000X | Ophthalmology | Q7717 (Texas) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Dejean And Kuglen Eye Associates Llp | 8527041128 | 9 |
News Archive
Large infants, and those who grow rapidly during the first two years of life, are at increased risk of obesity in childhood and adulthood, a study published online by the British Medical Journal today (14 October 2005) has found.
The first large-scale study of autism in China has revealed that around one in a hundred people in the country has an autism spectrum condition - the same figure as found in the West.
Vicki and Fred Modell, co-founders of the Jeffrey Modell Foundation, today called upon governors, state public health officials, and legislators, in all states, to implement screening of newborns with Severe Combined Immune Deficiency (SCID).
A UK wide research strategy to support the development of robust evidence to inform commissioning and clinical decision making is needed if pharmacy services are to be integrated into care pathways says the Pharmacy Practice Research Trust (the Trust) in a response to the UK Government's white paper on the future of pharmacy.
Results of a SWOG clinical trial published August 2 in the New England Journal of Medicine show the combination of anastrozole and fulvestrant extended the median survival time of women with hormone receptor-positive metastatic breast cancer by more than six months compared to women treated with a standard therapy of anastrozole alone (47.7 months vs 41.3 months).
› Verified 3 days ago
Entity Name | University Of Texas Southwestern Medical Center At Dallas |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972579365 PECOS PAC ID: 0648188250 Enrollment ID: O20031106000792 |
News Archive
Large infants, and those who grow rapidly during the first two years of life, are at increased risk of obesity in childhood and adulthood, a study published online by the British Medical Journal today (14 October 2005) has found.
The first large-scale study of autism in China has revealed that around one in a hundred people in the country has an autism spectrum condition - the same figure as found in the West.
Vicki and Fred Modell, co-founders of the Jeffrey Modell Foundation, today called upon governors, state public health officials, and legislators, in all states, to implement screening of newborns with Severe Combined Immune Deficiency (SCID).
A UK wide research strategy to support the development of robust evidence to inform commissioning and clinical decision making is needed if pharmacy services are to be integrated into care pathways says the Pharmacy Practice Research Trust (the Trust) in a response to the UK Government's white paper on the future of pharmacy.
Results of a SWOG clinical trial published August 2 in the New England Journal of Medicine show the combination of anastrozole and fulvestrant extended the median survival time of women with hormone receptor-positive metastatic breast cancer by more than six months compared to women treated with a standard therapy of anastrozole alone (47.7 months vs 41.3 months).
› Verified 3 days ago
Entity Name | Dejean & Kuglen Eye Associates Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1952322067 PECOS PAC ID: 8527041128 Enrollment ID: O20040612000114 |
News Archive
Large infants, and those who grow rapidly during the first two years of life, are at increased risk of obesity in childhood and adulthood, a study published online by the British Medical Journal today (14 October 2005) has found.
The first large-scale study of autism in China has revealed that around one in a hundred people in the country has an autism spectrum condition - the same figure as found in the West.
Vicki and Fred Modell, co-founders of the Jeffrey Modell Foundation, today called upon governors, state public health officials, and legislators, in all states, to implement screening of newborns with Severe Combined Immune Deficiency (SCID).
A UK wide research strategy to support the development of robust evidence to inform commissioning and clinical decision making is needed if pharmacy services are to be integrated into care pathways says the Pharmacy Practice Research Trust (the Trust) in a response to the UK Government's white paper on the future of pharmacy.
Results of a SWOG clinical trial published August 2 in the New England Journal of Medicine show the combination of anastrozole and fulvestrant extended the median survival time of women with hormone receptor-positive metastatic breast cancer by more than six months compared to women treated with a standard therapy of anastrozole alone (47.7 months vs 41.3 months).
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Jonathan T Jan, MD 400 S Loop 336 W, Conroe, TX 77304-3302 Ph: (936) 539-4500 | Jonathan T Jan, MD 400 S Loop 336 W, Conroe, TX 77304-3302 Ph: (936) 539-4500 |
News Archive
Large infants, and those who grow rapidly during the first two years of life, are at increased risk of obesity in childhood and adulthood, a study published online by the British Medical Journal today (14 October 2005) has found.
The first large-scale study of autism in China has revealed that around one in a hundred people in the country has an autism spectrum condition - the same figure as found in the West.
Vicki and Fred Modell, co-founders of the Jeffrey Modell Foundation, today called upon governors, state public health officials, and legislators, in all states, to implement screening of newborns with Severe Combined Immune Deficiency (SCID).
A UK wide research strategy to support the development of robust evidence to inform commissioning and clinical decision making is needed if pharmacy services are to be integrated into care pathways says the Pharmacy Practice Research Trust (the Trust) in a response to the UK Government's white paper on the future of pharmacy.
Results of a SWOG clinical trial published August 2 in the New England Journal of Medicine show the combination of anastrozole and fulvestrant extended the median survival time of women with hormone receptor-positive metastatic breast cancer by more than six months compared to women treated with a standard therapy of anastrozole alone (47.7 months vs 41.3 months).
› Verified 3 days ago
Timothy Wayne Doucet, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 400 S Loop 336 W, Conroe, TX 77304 Phone: 936-539-4500 Fax: 936-539-4050 | |
Mark Schering Jenkins, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 333 N. Rivershire Dr., Suite 160, Conroe, TX 77304 Phone: 936-441-2020 Fax: 936-756-0656 | |
Charles Downey Price, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 333 N. Rivershire Dr., Suite 160, Conroe, TX 77304 Phone: 936-441-2020 Fax: 936-756-0656 | |
Mark Howard Wilkerson, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 400 S Loop 336 W, Conroe, TX 77304 Phone: 936-539-4500 Fax: 936-539-4050 | |
Susan Kersey Fish, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 333 N. Rivershire Dr., Suite 160, Conroe, TX 77304 Phone: 936-441-2020 Fax: 936-756-0656 | |
Craig C Kuglen Jr., M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 400 S Loop 336 W, Conroe, TX 77304 Phone: 936-539-4500 Fax: 936-539-1216 | |
Baptiste John Dejean Iii, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 400 S Loop 336 W, Conroe, TX 77304 Phone: 936-539-4500 Fax: 936-539-4050 |